Nonetheless, a relevant percentage of SLE patients with erosive arthritis is ACPA negative, suggesting a different pathogenic scenario. In order to fill this space, also anti-CarP have been evaluated in SLE cohorts. Here, PRTN3 is linked to systemic lupus erythematosus.